< Property Suppliers>

Research Grade Ponezumab (DHK08301)

Product detail:

Published date: 2024-04-10 19:22:06

CAS number: 1178862-65-1

Name: Ponezumab

Price:
¥Inquiry/1kg ¥Inquiry/1g ¥Inquiry/1mg ¥Inquiry/1ton

Purity: 1.0%

Stocking period: Inquiry

Stock: Inquiry

Product Webpage: https://www.antibodysystem.com/product/437.html

Detail Product Information:
Catalog No.
DHK08301

Host species
Humanized

Species reactivity
Human

Form
Liquid

Storage buffer
0.01M PBS, pH 7.4.

Concentration
1 mg/ml

Purity
>95% by SDS-PAGE.

Clonality
Monoclonal

Isotype
IgG2-kappa

Applications
Research Grade Biosimilar

Target
AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50

Purification
Protein A or G purified from cell culture supernatant.

Endotoxin level
Please contact with the lab for this information.

Expression system
XtenCHO

Accession
P05067

Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Alternative Names
PF-04360365, RN-1219, clone 9TL, CAS: 1178862-65-1

Note
For research use only. Not suitable for clinical or therapeutic use.

Supplier/Manufacture:

Name: Biolab Reagents

Chemsrc Level: Unverified

Product #: 50

Tel: 027-65279366

Address: Building C, No. 666, Shen Dun Si Lu Wuhan, CHINA

Area: China(Mainland)

Contact: fang

Contact Phone #: 18108604356

Email: info@biolabreagent.com

Website: https://www.biolabreagent.com/

Annual Trade Volume:

Foreign Trade % of Salers:

Major partners: AntibodySystem

Detail introduction:
Wuhan Biolab Reagents was founded in 2021. Its core founding team comprises five tier researchers in the life sciences, graduates of Wuhan University, Huazhong University of Science and Technology, Huazhong Agricultural University, and other leading institutions. With over two decades of collective industry experience, the team has built solid capabilities in product development and applied technology, laying a robust technological foundation for the company.

Recognized as a National High-tech Enterprise and a National Technology-based SME, the company’s technical expertise has received authoritative endorsement. It also holds dual certification under ISO9001 and ISO13485 quality management systems, ensuring standardized quality control and reliable product performance. Leveraging globally advanced technology platforms, Biolab Reagents focuses on the global development and integration of high-quality biological reagents. It serves as the exclusive authorized partner in Asia for France’s AntibodySystem and as an agent for Sangon Biotech’s KleanAB brand. The company currently boasts a product portfolio of approximately 60,000 reagents, with core offerings spanning proteins, antibodies, and assay kits. These products primarily support research in areas such as oncology and neurological diseases, catering to diverse scientific needs.

Since its inception, Biolab Reagents has been committed to providing researchers and industrial clients in biomedicine with professional products and technical support. By offering premium research tools, the company empowers scientific exploration and contributes to innovation and breakthroughs in life sciences research.

Top suppliers:

No recommended suppliers


Get all suppliers by the below link:

Ponezumab suppliers

Price from the other suppliers:

2026-03-09 Ponezumab

2023-02-09 Ponezumab

2026-04-15 Ponezumab

Get all price from the following link:

Ponezumab price